Newsroom

This page contains up-to-date information on the global intellectual property proceedings relating to CRISPR-Cas9 gene editing, as well as relevant press coverage and answers to frequently asked questions.

US Legal Events

U.S. Patent and Trademark Office issued U.S. Patent No. 10,266,850 (‘the ‘850 patent), to The Regents of the University of California, the University of Vienna, and Dr. Emmanuelle Charpentier

April 23, 2019
Read more Arrow right

U.S. patent office issued third CRISPR patent to CVC; indicates it will issue a fourth

March 12, 2019
Read more Arrow right

U.S. patent office indicates it will issue third CRISPR patent to UC

February 8, 2019
Read more Arrow right
View allArrow-right

FAQ

We answer some commonly asked questions on the CRISPR-Cas9 intellectual property situation globally.

Learn more Arrow-right

International Patent Landscape

European Patent Office (EPO) awarded the Doudna-Charpentier team a broad CRISPR-Cas9 patent (EP Patent No. 3 401 400)

April 3, 2019
Read more Arrow right

“Europe: Legal issues lead to invalidation of second Broad patent; significant reduction in scope of third Broad patent”

February 15, 2019
Read more Arrow right

Europe: Doudna-Charpentier team awarded European patents

March 9, 2018
Read more Arrow right
View allArrow-right

Press

Emmanuelle Charpentier and Jennifer A. Doudna among the 2018 Kavli Award winners

June 11, 2018
Read more Arrow right

Broad Institute takes a hit in European CRISPR patent struggle

January 18, 2018
Read more Arrow right

China Sides with Emmanuelle Charpentier and Jennifer Doudna in CRISPR Patent War

June 19, 2017
Read more Arrow right
View allArrow-right